L'Oréal at €444, with Estée Lauder as the foil

L'Oréal's new high, Estée Lauder's different problem

L'Oréal is not being priced like a sleepy consumer staple. It is being priced like a company that keeps taking share in a beauty market that still has room for premium skincare, fragrance, professional haircare, and dermatological lines to do the heavy lifting. That matters because the stock is already near the top of its range, and the market is paying for continuity, not just for one good quarter. In a market like this, the premium is not only about growth, but about the quality of that growth. L'Oréal has been able to show that its sales engine is not dependent on one region, one category, or one channel, which is exactly the sort of profile investors tend to reward when the broader consumer backdrop is uneven.

Estée Lauder is the useful foil here because it sits in the same broad beauty universe, but the comparison is not symmetrical. L'Oréal has the broader engine, the cleaner recent sales print, and the more balanced mix across mass, luxury, professional, and dermocosmetics. Estée Lauder has its own strengths, but it is the name you use when you want to test whether the market is rewarding a category leader or just a luxury rebound. That distinction matters because the market is not simply choosing between two beauty stocks. It is choosing between two different operating models, two different degrees of resilience, and two different ways of converting sector demand into shareholder returns.

The quarter that keeps L'Oréal ahead of the pack

L'Oréal's latest material update came on October 22, when it reported nine-month 2026 sales of €35.33 billion, up 6.9% like-for-like and 7.7% reported. The third quarter was stronger still, with adjusted like-for-like growth of 7.7%, ahead of Visible Alpha consensus at 5.9%. Reuters said China demand picked up, and the company said it continued to outpace the global beauty market. That combination is important because it shows the company is not merely defending share in a stable market. It is still pushing ahead of expectations in a category where investors have become used to separating the leaders from the laggards.

The division mix was broad rather than narrow. Professional Products and Dermatological Beauty each posted adjusted like-for-like gains of 13.9% in Q3, L'Oréal Luxe rose 7.0%, and Consumer Products advanced 3.8%. That is the sort of spread that tells you the business is not leaning on one hero category. It is getting help from several shelves at once. The practical implication is that L'Oréal can absorb weakness in one pocket without losing the overall narrative. If consumer products are slower, professional and dermocosmetics can carry more of the load. If luxury is stronger, that adds another layer rather than becoming the whole story.

Against Estée Lauder, that breadth matters. A luxury-heavy beauty name can look powerful when prestige demand is hot, but it can also get pinned to a narrower set of regional and channel assumptions. L'Oréal's latest numbers show a company that is still growing across multiple engines, which is why the market has been willing to push the shares to a fresh high even after a strong year already. The comparison is not just about who grew faster in one quarter. It is about which business model gives investors more confidence that growth can persist without requiring a perfect backdrop.

Why the stock can sit near €444 and still look expensive for a reason

The shares traded around €444 on November 5, after hitting €453.20 earlier in the session. The prior close was €445.30 on November 4, and pre-market indications had pointed to a roughly 0.6% dip at one point. Year to date, the stock has advanced more than 21%. That is a meaningful move for a large-cap consumer name, and it tells you the market has already done a lot of the work of re-rating the stock. Yet the move has not been random. It has been anchored in a sequence of sales beats, broadening growth, and a sector backdrop that still favors the stronger brands.

That kind of move changes the burden of proof. When a stock has already re-rated, the market starts asking whether the next leg comes from another clean quarter, a margin surprise, or a broader rerating of the sector. L'Oréal has at least two of those ingredients in play. It has the sales momentum, and it has a sector backdrop that still favors premiumization, fragrance, and dermocosmetics. The stock therefore looks expensive in the abstract, but not obviously stretched relative to the operating evidence. That is a subtle but important distinction. A high multiple is easier to defend when the company keeps delivering broad-based growth and the market can see multiple avenues for that growth to continue.

Estée Lauder does not give you the same comfort. It can rally, and it has had periods of strength, but the comparison is useful precisely because it reminds you that not every beauty name is being rewarded for the same reason. L'Oréal is being rewarded for execution across categories and regions, not just for a single rebound narrative. That is a different kind of market support. It also means the stock's current level is not simply a function of sentiment. It reflects a judgment that the company has earned the right to trade at a premium because the underlying business has kept compounding.

What the insider sales add, and what they do not

The insider record is not the headline here, but it is part of the picture. Recent insider activity includes share sales by Chairman Jean-Paul Agon and CEO Nicolas Hieronimus in October 2026, according to Insiderscreener. Those sales came after the stock had already moved into multi-year-high territory, which makes them easier to read as liquidity events than as a fresh directional call on the business. That timing matters. Insider selling after a strong run can reflect portfolio management, tax planning, or routine diversification. It does not automatically mean the leadership team has lost confidence in the company’s trajectory.

That is where the comparison with Estée Lauder matters again. At a company like L'Oréal, where the operating story is already strong and the share price has done a lot of the work, insider selling does not automatically change the thesis. It does, however, tell you that the top of the house is not leaning into the stock with fresh open-market buying at these levels. That is a nuance worth keeping in view when the chart is already extended. In a head-to-head comparison, that nuance matters because it separates operational strength from insider conviction. L'Oréal can still be the better business even if insiders are not adding aggressively at the current price.

Insiders Trades data puts the historical T+90 cohort return for this role-and-size bucket at +2.6%, with a 54% win rate. That is historical cohort data, not a forecast for L'Oréal, and it does not tell you what this specific stock will do next. It does tell you that, in this bucket, the average post-filing path has been positive but hardly explosive. The filing is a signal, not a guarantee, and the market still has to decide whether the company keeps compounding at the pace the last quarter implied. In other words, the cohort data supports a cautious reading of the insider sales: useful context, but not a thesis in itself.

Beauty demand still favors the bigger engine

The sector backdrop is still doing work for L'Oréal. Recent outlooks have pointed to fragrance as a standout category, growing around 10%, alongside premium skincare, professional haircare, and dermatological lines. That is the mix L'Oréal is built to exploit. It is also why the company can keep outgrowing the broader market without needing a single macro tailwind to do all the lifting. The point is not that the beauty market is booming uniformly. It is that the parts of the market that are still strongest happen to align with L'Oréal's most advantaged categories.

The broader beauty, health, and wellness space is projected above $900 billion, with services accounting for more than half of spend and consumers prioritizing functional and emotional value. That is a big umbrella, but the useful point is narrower. The categories that are still winning are the ones where L'Oréal has scale, brand depth, and distribution reach. Estée Lauder can participate in that same demand, but L'Oréal has the wider platform. In a head-to-head frame, that means L'Oréal is not just riding the same wave. It has more boards in the water.

Reuters noted that China demand picked up in the latest quarter, and that matters because the market has spent a lot of time worrying about Chinese consumer demand across luxury and prestige categories. L'Oréal did not need a perfect China backdrop to post a strong quarter, but a better one helps. It also helps explain why the stock can hold near highs even after a strong run. When the market sees evidence that one of the most closely watched demand regions is improving, it becomes easier to justify paying up for the company that is already executing well elsewhere.

The comparison with Estée Lauder is really about breadth

If you want the cleanest head-to-head, you do not start with valuation alone. You start with execution breadth. L'Oréal just posted growth across all four divisions, with especially strong numbers in Professional Products and Dermatological Beauty. That is a company with multiple ways to win. Estée Lauder, by contrast, is a more concentrated read on luxury beauty and the pace of recovery in its key channels. The difference is not cosmetic. It changes how much confidence investors can place in the next quarter, and how much they need to assume about the consumer environment.

That difference shows up in how the market treats the two names. L'Oréal has been able to lean on premiumization, innovation, and e-commerce strength while still keeping the mass market relevant. The company said e-commerce sales grew around 17%, which is another reminder that the growth is not confined to one channel. Estée Lauder can certainly benefit from digital and prestige demand, but it does not have the same breadth of levers. A broader channel mix also reduces the risk that one weak channel can dominate the narrative. That is especially valuable in a market where investors are increasingly selective about which consumer names deserve premium valuations.

The result is that L'Oréal can look expensive and still be easier to justify than a peer with a narrower base. That is not a blank cheque. It is a recognition that the company has been delivering the sort of broad-based growth that supports a premium multiple, especially when the sector itself is still favoring the stronger operators. In the comparison with Estée Lauder, the key point is not that L'Oréal is immune to disappointment. It is that the company has more layers of support if one part of the business slows.

November 30 is the next checkpoint, not the whole story

A capital markets day is scheduled for November 30, and that gives the market a near-term event to price. It is the next obvious checkpoint for anyone trying to decide whether the current run can extend or whether the stock needs a pause after a strong year. The event matters because L'Oréal has already done the hard part, which is to keep growth broad enough that the market still believes the story. In a head-to-head with Estée Lauder, that upcoming event also matters because it can reinforce the gap between a company with visible momentum and one that still has more proving to do.

The risk is straightforward. When a stock is near a fresh high, expectations get less forgiving. If management sounds cautious, or if the market decides the recent sales pace is hard to repeat, the shares can cool quickly. That is true for L'Oréal, and it is also why the insider sales matter as context. They do not break the story, but they do sit alongside a stock that has already had a good year. The market is likely to scrutinize not just the headline growth rate, but whether the company can keep all four divisions moving in the same direction while preserving the premium narrative.

Estée Lauder will keep serving as the comparison point because it shows what a less balanced beauty story looks like when the market is trying to separate rebound from durability. L'Oréal has the stronger recent numbers, the broader category exposure, and the cleaner momentum. The question into November 30 is whether that combination keeps earning the premium, with the stock already around €444 and the next formal update only weeks away. If the company confirms that the broad-based pattern is intact, the comparison with Estée Lauder becomes even more favorable. If not, the market may decide that the gap between the two names is still justified, but not necessarily widening.

This is not investment advice.